Cornerstone Planning Group LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1822587
FAIRFIELD, NJ
Position in HALO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$30,447
+$11,899 QoQ
Shares Held
389
+35.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#548
of 667 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cornerstone Planning Group LLC holds $333,862 across 45 Biotechnology names. HALO ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130 | $64,574 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
199 | $37,268 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
389 | $30,447 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
97 | $29,199 | |
| 5 | RPRX |
Royalty Pharma plc
|
373 | $20,914 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 7 | ARGX |
Argenx SE
|
17 | $15,772 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
2,000 | $15,700 |
All Filings in HALO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,447 | 389 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $18,548 | 287 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $19,315 | 287 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $21,121 | 288 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $416 | 8 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,340 | 21 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $382 | 8 | Shares | Sole | 2025-01-29 | |
| 2023-06-30 | $937 | 26 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $1,251 | 22 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||